Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Catheter Precision, Inc. Common Stock
(NY:
VTAK
)
2.270
-0.130 (-5.42%)
Official Closing Price
Updated: 8:00 PM EST, Nov 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Catheter Precision, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Spotlighting Noteworthy Companies, Insights and Recent News Cycles: FFIE, VTAK, ASTI, BNED, PEGY
June 04, 2024
Via
AB Newswire
“Cutting-Edge Medical Innovations Propel Catheter Precision Inc. (NYSE American: VTAK) Forward”
May 24, 2024
Via
AB Newswire
Top Stocks to Watch: FFIE, PLUG, SPWR, More Inside!
May 15, 2024
Via
AB Newswire
Spotlight: Healthcare and Tech VTAK, ORGO, CDIO, LAZR, VLCN
May 13, 2024
Via
AB Newswire
Catheter Precision, Inc. (NYSE: VTAK) Announces Initial Orders from Ronald Reagan UCLA Medical Center and Rady Children’s Hospital in San Diego for LockeT
May 13, 2024
Via
ACCESSWIRE
Catheter Precision, Inc. (VTAK) Announces Receipt of New Purchase Order and Product Evaluation at New Hospital
May 07, 2024
Via
ACCESSWIRE
Market Movers on The Street: LAZR, INBS, REBN, PSRO
May 10, 2024
Via
AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Announces Purchase Order From University of California San Diego (UCSD) Health System
May 08, 2024
Via
AB Newswire
Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS
May 08, 2024
Via
AB Newswire
VTAK Stock Earnings: Catheter Precision, Inc. Common Stock Beats EPS, Misses Revenue for Q1 2024
May 07, 2024
VTAK stock results show that Catheter Precision, Inc. Common Stock beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance Report
May 06, 2024
Via
ACCESSWIRE
Catheter Precision, Inc. (NYSE-American: VTAK) Announces New Chief Commercial Officer
May 01, 2024
Via
ACCESSWIRE
Discovering Undervalued Stocks in Today’s Market: OCGN, INBS, KAVL, DYAI, VTAK
April 29, 2024
Via
AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Stock Surges Following LockeT Purchase Order from HCA Healthcare
April 26, 2024
Via
AB Newswire
Stocks Creating Buzz Look Now: VTAK, AMST, HOOK, MULN, KAVL
April 26, 2024
Via
AB Newswire
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 24, 2024
Via
Benzinga
Catheter Precision, Inc. (VTAK) Announces Receipt of First Purchase Order for LockeT from HCA Healthcare Facility
April 24, 2024
Via
ACCESSWIRE
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
April 19, 2024
Via
AB Newswire
Medical Device Innovator Catheter Precision Inc. (NYSE American: VTAK) Gains Momentum with LockeT and VIVO™ Products – Full Analysis Inside!
April 18, 2024
Via
AB Newswire
Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB
April 15, 2024
Via
AB Newswire
Topics
Intellectual Property
Ladenburg Thalmann, Esteemed Wall Street Long-Standing Stalwart Since 1876, Advocates ‘Buy’ for Intelligent Bio, Precision Bio, and More: VTAK, INBS, LASE, MYMD, RVSN
April 09, 2024
Via
AB Newswire
Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements
April 05, 2024
Via
AB Newswire
Catheter Precision (NYSE American: VTAK) Shows Fiscal Strength, Solid Growth and Strategic Moves; Bullish Momentum Seen in Stock Price
April 04, 2024
Via
AB Newswire
Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year
April 04, 2024
Via
ACCESSWIRE
Catheter Precision, Inc. (NYSE American:VTAK) Releases Operational Performance Report, Q4 and Annual 2023 Financials for Year Ending December 31, 2023
April 01, 2024
Via
ACCESSWIRE
March Madness 2024: Key Players in Medical Tech, Healthcare and AI: INBS, AMTX, VTAK, ANGH, TRUG
March 21, 2024
Via
AB Newswire
Topics
Energy
Catheter Precision Inc. (NYSE American: VTAK) Surges with VIVO™ Success
March 19, 2024
Via
AB Newswire
Catheter Precision, Inc. (NYSE American:VTAK) to Sponsor the Monaco USA Arrhythmia Course
March 19, 2024
Via
ACCESSWIRE
Catheter Precision, Inc. (NYSE American:VTAK) Announces the First use of VIVO in Qatar
March 14, 2024
Via
ACCESSWIRE
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
March 13, 2024
Via
AB Newswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today